Regeneron Pharmaceuticals has won FDA accelerated approval of its Lynozyfic treatment for certain patients with the blood ...

Dr. George Tidmarsh, physician, scientist, and biotech CEO, joins Jerry Rogers on "The Business of America" podcast to ...

The U.S. Food and Drug Administration has approved Regeneron's cancer therapy, the company said on Wednesday, providing ...

The FDA cleared an artificial intelligence (AI)-powered wristband (Felix NeuroAI) to treat upper-limb functional limitations ...

Alma Pak International LLC issued a voluntary recall for 400 boxes of its organic blueberries on June 9 due to possible listeria contamination.

A young Pittsburgh-area police officer died by suicide and pointed to Lasik eye surgery complications as the reason. Now his ...

Updated label allows Neuraceq to be used in selecting patients for amyloid-targeting therapies and includes the use of ...

The safety update for Vyvgart rattled argenx’s shares on Monday, a reaction that analysts at William Blair said was “overdone ...

The wearable, transcutaneous neurostimulation device delivers personalized therapy using a proprietary AI algorithm.

This approval comes almost a year after the drug received a complete response letter due to third-party manufacturing issues.

Sabores Fit Bakery recalled a variety of its mousse desserts on June 20 because of the undeclared presence of allergens.

The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to ...